NuGen Medical Devices Inc. (TSXV: NGMD)
Canada
· Delayed Price · Currency is CAD 0.0800
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST
NuGen Medical Devices Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Net Income | -8.31 | -9.36 | -5.58 | -7.11 | -3.67 | -1.98 | Upgrade
|
| Depreciation & Amortization | 0.64 | 0.69 | 0.65 | 0.63 | 0.38 | 0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.16 | 0.02 | - | Upgrade
|
| Stock-Based Compensation | 0.54 | 1.36 | 0.43 | 1.31 | 0.16 | 0.02 | Upgrade
|
| Other Operating Activities | 1.74 | 1.32 | 1.76 | 1.14 | 1.06 | 0.08 | Upgrade
|
| Change in Accounts Receivable | 0.06 | -0.02 | 0.01 | -0.01 | 0.01 | 0 | Upgrade
|
| Change in Inventory | -0.25 | -0.13 | -0.06 | -0 | 0 | - | Upgrade
|
| Change in Accounts Payable | 1.54 | -0.36 | 0.61 | -0.03 | 0.44 | 0.33 | Upgrade
|
| Change in Unearned Revenue | 0.23 | 0.02 | 0.04 | - | - | - | Upgrade
|
| Change in Income Taxes | - | - | - | - | 0.11 | -0.11 | Upgrade
|
| Change in Other Net Operating Assets | 0.66 | -0.23 | 0.02 | -0.19 | 0.1 | -0.17 | Upgrade
|
| Operating Cash Flow | -3.17 | -6.71 | -2.13 | -4.1 | -1.39 | -1.81 | Upgrade
|
| Capital Expenditures | -0 | -0 | -0 | -0 | -0.01 | - | Upgrade
|
| Cash Acquisitions | - | - | - | 0.01 | 0.06 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -0.06 | Upgrade
|
| Other Investing Activities | -0 | -0.05 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0 | -0.05 | -0 | 0 | 0.05 | -0.06 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 0.13 | 0.73 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.87 | -0.08 | -0.05 | - | -0.03 | Upgrade
|
| Net Debt Issued (Repaid) | 9.98 | -0.87 | -0.08 | 0.08 | 0.73 | -0.03 | Upgrade
|
| Issuance of Common Stock | 0.87 | 7.97 | 0.67 | 5.51 | 0.89 | - | Upgrade
|
| Other Financing Activities | - | - | -0.08 | - | - | -0.1 | Upgrade
|
| Financing Cash Flow | 10.85 | 7.1 | 0.51 | 5.58 | 1.62 | -0.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | -0.02 | -0 | -0.02 | Upgrade
|
| Net Cash Flow | 7.68 | 0.33 | -1.62 | 1.47 | 0.27 | -2.01 | Upgrade
|
| Free Cash Flow | -3.17 | -6.72 | -2.13 | -4.1 | -1.4 | -1.81 | Upgrade
|
| Free Cash Flow Margin | -415.82% | -2026.89% | -1399.36% | -2977.84% | -2958.59% | - | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.04 | -0.02 | -0.06 | -0.03 | -0.08 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.01 | 0 | - | Upgrade
|
| Cash Income Tax Paid | 0.01 | 0.01 | 0 | 0 | - | - | Upgrade
|
| Levered Free Cash Flow | -1.56 | -4.59 | -2.29 | -2.64 | -0.8 | -1.19 | Upgrade
|
| Unlevered Free Cash Flow | -0.76 | -3.82 | -1.66 | -1.88 | -0.54 | -1.12 | Upgrade
|
| Change in Net Working Capital | -2.11 | 0.84 | -0.26 | 0.19 | -0.55 | -0.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.